Cargando…

ADAMTS13 Predicts Renal and Cardiovascular Events in Type 2 Diabetic Patients and Response to Therapy

In patients with diabetes, impaired ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) proteolysis of highly thrombogenic von Willebrand factor (VWF) multimers may accelerate renal and cardiovascular complications. Restoring physiological VWF handling might co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rurali, Erica, Noris, Marina, Chianca, Antonietta, Donadelli, Roberta, Banterla, Federica, Galbusera, Miriam, Gherardi, Giulia, Gastoldi, Sara, Parvanova, Aneliya, Iliev, Ilian, Bossi, Antonio, Haefliger, Carolina, Trevisan, Roberto, Remuzzi, Giuseppe, Ruggenenti, Piero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781447/ https://www.ncbi.nlm.nih.gov/pubmed/23733198 http://dx.doi.org/10.2337/db13-0530

Ejemplares similares

Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes
por: Valoti, Elisabetta, et al.
Publicado: (2019)

Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A prospective randomized double-blind clinical trial
por: Ruggenenti, Piero, et al.
Publicado: (2010)

Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)
por: Ruggenenti, Piero, et al.
Publicado: (2008)

Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
por: Ruggenenti, Piero, et al.
Publicado: (2012)

Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis
por: Curtò, Diego, et al.
Publicado: (2021)

SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation
por: Perico, Luca, et al.
Publicado: (2022)

Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial
por: Ruggenenti, Piero, et al.
Publicado: (2010)

Preventing microalbuminuria with benazepril, valsartan, and benazepril–valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study
por: Ruggenenti, Piero, et al.
Publicado: (2021)

C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19
por: Aiello, Sistiana, et al.
Publicado: (2022)

Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study
por: Ruggenenti, Piero, et al.
Publicado: (2021)

Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial
por: Parvanova, Aneliya, et al.
Publicado: (2018)

Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19
por: Leone, Valentina Fanny, et al.
Publicado: (2022)

Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant
por: Piras, Rossella, et al.
Publicado: (2020)

An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome
por: Gastoldi, Sara, et al.
Publicado: (2023)

Impact of the PPAR-γ2 Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICT
por: De Cosmo, Salvatore, et al.
Publicado: (2009)

Full-dose NSAIDs at the first sign of respiratory infection? – Authors’ reply
por: Ruggenenti, Piero, et al.
Publicado: (2022)

Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination
por: Sharma, Sanjib Kumar, et al.
Publicado: (2007)

Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?
por: Cravedi, Paolo, et al.
Publicado: (2010)

Hereditary ADAMTS 13 deficiency presenting as recurrent acute kidney injury
por: Jamale, T. E., et al.
Publicado: (2012)

Functional Magnetic Resonance Imaging Versus Kidney Biopsy to Assess Response to Therapy in Nephrotic Syndrome: A Case Report
por: Caroli, Anna, et al.
Publicado: (2020)

A GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by Neanderthals
por: Breno, Matteo, et al.
Publicado: (2023)

Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN
por: Donadelli, Roberta, et al.
Publicado: (2018)

Amnion epithelial cells are an effective source of factor H and prevent kidney complement deposition in factor H-deficient mice
por: Casiraghi, Federica, et al.
Publicado: (2021)

Data on the assessment of LV mechanics by speckle tracking echocardiography in ADPKD patients
por: Spinelli, Letizia, et al.
Publicado: (2018)

CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome
por: Piras, Rossella, et al.
Publicado: (2023)

Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome
por: Perna, Annalisa, et al.
Publicado: (2022)

Complement Factor H Gene Abnormalities in Haemolytic Uraemic Syndrome: From Point Mutations to Hybrid Gene
por: Noris, Marina, et al.
Publicado: (2006)

Overview of Complement Activation and Regulation
por: Noris, Marina, et al.
Publicado: (2013)

Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015
por: Noris, Marina, et al.
Publicado: (2015)

Non-muscle myosins and the podocyte
por: Noris, Marina, et al.
Publicado: (2012)

Every Fifteen Days Forever?
por: Noris, Marina, et al.
Publicado: (2022)

ADAMTS-9 in Mouse Cartilage Has Aggrecanase Activity That Is Distinct from ADAMTS-4 and ADAMTS-5
por: Rogerson, Fraser M., et al.
Publicado: (2019)

The ADAMTS/Fibrillin Connection: Insights into the Biological Functions of ADAMTS10 and ADAMTS17 and Their Respective Sister Proteases
por: Karoulias, Stylianos Z., et al.
Publicado: (2020)

The emerging roles of ADAMTS-7 and ADAMTS-12 matrix metalloproteinases
por: Lin, Edward A, et al.
Publicado: (2009)

ADAMTS9, a member of the ADAMTS family, in Xenopus development
por: Desanlis, Ines, et al.
Publicado: (2018)

Matrilin-2 Is Proteolytically Cleaved by ADAMTS-4 and ADAMTS-5
por: Wang, Zhengke, et al.
Publicado: (2014)

ADAMTS2 and ADAMTS14 can substitute for ADAMTS3 in adults for pro-VEGFC activation and lymphatic homeostasis
por: Dupont, Laura, et al.
Publicado: (2022)

Perioperative Minimal Induction Therapy: A Further Step toward More Effective Immunosuppression in Transplantation
por: Gennarini, Alessia, et al.
Publicado: (2012)

Regulation of ADAMTS Proteases
por: Rose, Keron W. J., et al.
Publicado: (2021)

The case of complement activation in COVID-19 multiorgan impact
por: Noris, Marina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bc8gju00e351fapr3fekciv580